ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study

Patients with atrial fibrillation are often elderly and have multiple comorbidities, leading to a high risk of cardiovascular events1,2,3 despite the use of oral anticoagulants, whether with vitamin K antagonists (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs).
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Clinical Research Study Source Type: research